Convatec Group PLC (CTEC)
Convatec Group PLC: Director/PDMR Shareholding

10-March-2023 / 11:45 GMT/BST

10 March 2023

Convatec Group Plc
(“Convatec” or “the Company”)

Director/ PDMR Shareholding 

The Company has been notified of the following transactions in relation to a Person Discharging Managerial Responsibility (“PDMR”) in respect of ordinary shares of 10 pence each in the Company (“Shares”).

On 9 March 2023, Shares awarded to Karim Bitar, the Company’s Chief Executive Officer on 6 March 2020 under the Company’s Deferred Bonus Plan vested, resulting in Karim receiving 59,055 Shares.

On the same date, 27,833 of these Shares were sold automatically on Karim’s behalf to satisfy income tax and national insurance liabilities arising in connection with the vesting of this award.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Karim Bitar

2

Reason for the notification

a)

Position/Status

   Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Convatec Group Plc

b)

LEI

213800LS272L4FIDOH92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary share of 10p each in Convatec Group Plc

 

GB00BD3VFW73

b)

Nature of the transaction

Vesting of the share award under the Company’s Deferred Bonus Plan, granted on 6 March 2020.

 

 

c)

Price(s) and volume(s)

Price(s)

   N/A

Volume(s)

    59,055

 

d)

Aggregated information

- Aggregated volume 

- Price

 

N/A

N/A

e)

Date of the transaction

2023-03-09

f)

Place of the transaction

Outside a trading venue

 

 

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Karim Bitar

2

Reason for the notification

a)

Position/Status

   Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Convatec Group Plc

b)

LEI

213800LS272L4FIDOH92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary share of 10p each in Convatec Group Plc

 

GB00BD3VFW73

b)

Nature of the transaction

Sale of shares arising from the vesting of the share award under the Deferred Bonus Plan, to meet income tax and social security liabilities due on vesting.

c)

Price(s) and volume(s)

Price(s)

2.2076

Volume(s)

27,833

d)

Aggregated information

- Aggregated volume 

- Price

 

N/A

N/A

e)

Date of the transaction

2023-03-09

f)

Place of the transaction

London Stock Exchange

 

 

 

 

 

 

 

 

 

 

Enquiries 

 

Louise Bryson, Assistant Company Secretary                                            +44(0)7423 694919

 

Cosec@convatec.com 

 

Convatec Group Plc’s LEI code is 213800LS272L4FIDOH92 

 

About Convatec 
 

Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence and critical care, and infusion care. With around 10,000 colleagues, we provide our products and services in almost 100 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Group revenues in 2022 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more about Convatec, please visit http://www.convatecgroup.com.

 


Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
ISIN: GB00BD3VFW73
Category Code: DSH
TIDM: CTEC
LEI Code: 213800LS272L4FIDOH92
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.: 229120
EQS News ID: 1579993

 
End of Announcement EQS News Service

fncls.ssp?fn=show_t_gif&application_id=1579993&application_name=news&site_id=webfg

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.